Ischemia modified albumin (IMA) is associated with peripheral arterial disease and dialysis modality in chronic hemodialysis patients
Not Applicable
Completed
- Conditions
- chronic hemodialysis patients
- Registration Number
- TCTR20200306001
- Lead Sponsor
- Ramathibodi hospital, Mahidol university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 210
Inclusion Criteria
Inclusion criteria included receipt of chronic HD treatments for >2 weeks, age > 15 years and ability to provide valid informed consent. Patients who declined to participate in the study were excluded
Exclusion Criteria
Patients who declined to participate in the study were excluded.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ankle-Brachial Index during study period ABI was measured using the vascular screening system (VaSera VS-2000, Fukuda Denshi, Japan)
- Secondary Outcome Measures
Name Time Method ischemia modified albumin during study period colorimetric method following reduction by dithiothreitol (DTT)